The area under the curve (AUC) values generated by ROC curve analyses to assess the performance of CSF YKL-40 as an AD marker to discriminate this group from non-demented controls, DLB and PD patients were 0.816, 0.736 and 0.818 respectively. This evidence concerns the gene CHI3L1 and Alzheimer disease.